<DOC>
	<DOCNO>NCT00106704</DOCNO>
	<brief_summary>The purpose clinical study determine safety efficacy investigational drug patient Type 2 diabetes mellitus .</brief_summary>
	<brief_title>Sulfonylurea Add-on Study Patients With Type 2 Diabetes Mellitus ( 0431-035 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients Type 2 Diabetes Mellitus inadequate glycemic control Patients Type 1 Diabetes Mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>